Enterprise Sales Executive

Adam Cox

More than fifteen years in enterprise software sales, the last ten selling into healthcare, one of the most complex and regulated industries there is. Six- and seven-figure deals with C-suite and VP buyers, 116% average quota attainment, a 202% peak in 2024, and 7x President's Club.

116%

Avg. Quota Attainment

President's Club

202%

Peak Year (2024)

Career

Where I've been.

2016 — Present

Strategic Account Executive · 4 promotions

Global Healthcare Exchange (GHX)

Strategic Account Executive at GHX, promoted four times in ten years. Sells an ERP-integrated cloud platform to medical device, pharmaceutical, and biotech manufacturers across an assigned named-account territory, winning net-new logos and growing existing accounts into multi-year, multi-product commitments. Averaged 116% across ten years. Peak of 202% in 2024. Named Salesperson of the Year.

2010 — 2016

Enterprise Account Executive

Quadient

Enterprise Account Executive at Quadient. Ranked #2 nationally in new account revenue in 2013 and 2014, grew the Colorado territory 46% year over year, and sold to companies across a broad mix of industries. Earned 2015 Top Performer, Colorado Region.

The Work

What I deliver

The Modernization Sale

The sale isn't the software. It's convincing a complex organization that what they've built around their current systems costs more than replacing them. I've been having that conversation for more than fifteen years.

Consultative Discovery

Diagnosing what an organization actually needs before talking product. Working across IT, operations, finance, and sales to get everyone pointing the same direction.

Selling the Network

GHX connects 1.3M+ trading partners. I don't sell software, I sell what happens when an organization is plugged into that network. It's a different conversation than a feature demo.

Business Case Development

Translating data from $128B+ in annual transaction volume into business cases that move executives from curiosity to commitment.

Key Verticals

Life Sciences Medical Device Manufacturers Pharmaceutical Suppliers Biotechnology Companies

Approach

How I sell

I ask better questions than anyone in the room.

Understanding the real problem, not the stated one, is where deals actually begin. Curiosity is the skill that doesn't show up on a quota report.

I know where the whitespace is.

Every hour I spend with a prospect is deliberate. I don't chase what doesn't fit. Knowing what to walk away from is as important as knowing what to pursue.

Numbers cut through noise.

First call or QBR, every conversation runs on the customer's own numbers. Abstract value propositions don't close enterprise deals. Quantified ROI does.

Closed-won is the beginning, not the end.

My highest-value relationships started as prospects that turned into multi-year expansions. I've never treated a signature as a finish line.

What's Next

Why AI. Why now.

For more than a decade, I've watched the industry with the highest stakes move slower than almost any other on technology adoption. The reasons aren't hard to understand: regulation, risk aversion, genuine fear of getting it wrong. But staying put has costs too. AI is the first thing I've seen that can actually shift that.

I've spent my career selling platforms where massive data flows meet operations that can't afford to fail. The companies building AI for the enterprise need sellers who know that territory. People who can walk into a room of skeptical VPs and make the abstract feel inevitable.

I'm already operating this way. I'm my sales team's Claude Champion: I built our Claude training, prompt library, and revenue tools, and I run office hours for 28 sellers. I use AI to run tailored outreach at scale, build executive-ready presentations faster than my competitors expect, and find the right opportunities before they know they exist. That's not aspirational. I already work this way.

Adam Cox

Where I've been.

What I deliver

How I sell

Why AI. Why now.

Awards

Let's talk.